Literature DB >> 628119

A modified, simple device for the emergency administration of percutaneous transtracheal ventilation.

L B Dunlap, E Oregon.   

Abstract

Studies of percutaneous transtracheal ventilation with intermittent jets of oxygen under high pressure have demonstrated a tendency toward carbon dioxide retention and poor alveolar washout. A modification of the percutaneous transtracheal ventilation fevice to include an expiratory phase improves pulmonary gas exchange and minimizes the possibility of CO2 retention. The most common complication is subcutaneous emphysema caused by incorrect catheter placement. Although endotracheal intubation is unquestionably the treatment of choice, percutaneous transtracheal ventilation does offer a viable alternative when intubation cannot be rapidly accomplished.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628119     DOI: 10.1016/s0361-1124(78)80034-3

Source DB:  PubMed          Journal:  JACEP        ISSN: 0361-1124


  5 in total

1.  [Preclinical transtracheal emergency ventilation. Animal experimental comparison of two techniques].

Authors:  K Schwarzkopf; L Hüter; N-P Preussler; R Schäfer; T Schreiber
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

2.  Otolaryngology/Head and neck surgery: emergency ventilation using transtracheal puncture and positive pressure oxygenation.

Authors:  E A Weymuller
Journal:  West J Med       Date:  1984-11

3.  The efficacy of three different methods of transtracheal ventilation.

Authors:  M H Zornow; T C Thomas; M S Scheller
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

4.  A new transtracheal catheter for ventilation and resuscitation.

Authors:  P Ravussin; J Freeman
Journal:  Can Anaesth Soc J       Date:  1985-01

5.  Rescue ventilation through a small-bore transtracheal cannula in severe hypoxic pigs using expiratory ventilation assistance.

Authors:  Ankie E Hamaekers; Tim van der Beek; Maurice Theunissen; Dietmar Enk
Journal:  Anesth Analg       Date:  2015-04       Impact factor: 5.108

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.